Scarica l'app Stockscreener
1.78
22.76%
0.33
Dopo l'orario di chiusura:
1.77
-0.01
-0.56%
Macrogenics Inc Borsa (MGNX) Ultime notizie
HAGENS BERMAN, SHAREHOLDER ADVOCATES, Encourages MacroGenics (MGNX) Investors With Significant Losses to Contact Its Attorneys, 6-Day Application Deadline is Approaching - ACCESS Newswire
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages MacroGenics (MGNX) Investors With Significant Losses to Contact Its Attorneys, 5-Day Application Deadline is Approaching in Securities Class Action - ACCESS Newswire
MacroGenics to Present at the Goldman Sachs 46th Annual Global H - GuruFocus
MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 | MGNX Stock News - GuruFocus
MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 - GlobeNewswire
MacroGenics Executives Set for Major Goldman Sachs Healthcare Conference Presentation: Watch Live - Stock Titan
Levi & Korsinsky Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024 – MGNX - ACCESS Newswire
MacroGenics (NASDAQ:MGNX) Upgraded to Hold at Wall Street Zen - Defense World
Levi & Korsinsky Notifies Shareholders of MacroGenics, Inc.(MGNX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
MacroGenics’ SWOT analysis: biotech firm’s stock faces pipeline challenges By Investing.com - Investing.com South Africa
MacroGenics’ SWOT analysis: biotech firm’s stock faces pipeline challenges - Investing.com
Lazard Asset Management LLC Purchases New Position in MacroGenics, Inc. (NASDAQ:MGNX) - Defense World
Northern Trust Corp Has $1.76 Million Stock Holdings in MacroGenics, Inc. (NASDAQ:MGNX) - Defense World
Millennium Management LLC Sells 671,179 Shares of MacroGenics, Inc. (NASDAQ:MGNX) - Defense World
Q2 Earnings Forecast for MacroGenics Issued By B. Riley - Defense World
MacroGenics Holds Annual Stockholders Meeting on May 21 - TipRanks
B. Riley Issues Pessimistic Forecast for MacroGenics (NASDAQ:MGNX) Stock Price - Defense World
Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies - Yahoo Finance
Analyst Forecasts For MacroGenics, Inc. (NASDAQ:MGNX) Are Surging Higher - simplywall.st
4 Analysts Assess Macrogenics: What You Need To Know - Benzinga
Macrogenics (MGNX) Target Price Reduced by B. Riley Securities | MGNX Stock News - GuruFocus
MacroGenics (MGNX) Sees Target Price Cut Amid Pipeline Focus | MGNX Stock News - GuruFocus
B. Riley Cuts Price Target on MacroGenics to $3 From $5, Keeps Neutral Rating - marketscreener.com
Macrogenics (MGNX) Target Price Reduced by B. Riley Securities | - GuruFocus
Stifel Nicolaus Cuts MacroGenics (NASDAQ:MGNX) Price Target to $5.00 - Defense World
Stifel Financial Corp Decreases Holdings in MacroGenics, Inc. (NASDAQ:MGNX) - Defense World
Leerink Partnrs Predicts Weaker Earnings for MacroGenics - Defense World
Drug developer stocks fall as companies navigate clinical roadblocks - BioWorld MedTech
Earnings Release: Here's Why Analysts Cut Their MacroGenics, Inc. (NASDAQ:MGNX) Price Target To US$4.50 - Yahoo Finance
MacroGenics Inc. Reports Q1 2025 Financial Results - TipRanks
Dimensional Fund Advisors LP Has $2.33 Million Position in MacroGenics, Inc. (NASDAQ:MGNX) - Defense World
MacroGenics (MGNX) Reports Q1 Loss, Lags Revenue Estimates - MSN
MGNX: Barclays Lowers Price Target for Macrogenics | MGNX Stock News - GuruFocus
Stifel cuts MacroGenics stock target to $5, maintains Hold rating By Investing.com - Investing.com Canada
MacroGenics (MGNX) Exceeds Revenue Expectations with Strong Pipe - GuruFocus
Macrogenics Inc (MGNX) Q1 2025 Earnings: EPS Loss of $0.65 Beats - GuruFocus
Macrogenics (MGNX) Receives Updated Price Target from Stifel | M - GuruFocus
MacroGenics (MGNX) Price Target Lowered by Stifel | MGNX Stock N - GuruFocus
MacroGenics (MGNX) Price Target Reduced by Barclays | MGNX Stock News - GuruFocus
MacroGenics price target lowered to $3 from $8 at Barclays - TipRanks
MacroGenics Inc earnings matched, revenue fell short of estimates By Investing.com - Investing.com India
MacroGenics: Q1 Earnings Snapshot - Huron Daily Tribune
MacroGenics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results - GlobeNewswire
MacroGenics Inc earnings matched, revenue fell short of estimates - Investing.com
Macrogenics Inc (MGNX) Q1 2025 Earnings: EPS Loss of $0.65 Beats Estimate, Revenue Soars to $13.2 Million, Surpassing Expectations - GuruFocus
MacroGenics reports Q1 EPS (65c), consensus (69c) - TipRanks
Analysts Set MacroGenics, Inc. (NASDAQ:MGNX) Target Price at $7.43 - Defense World
What To Expect From Macrogenics Inc (MGNX) Q1 2025 Earnings - GuruFocus
1.21%
1.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):